Two companies (Boston Scientific, Marlboro, Massachusetts, and Ambu A/S, Copenhagen, Denmark) have developed single-use duodenoscopes as a means for avoiding potential patient-to-patient transmission of infections. This set of articles presents data from simulated evaluation in a synthetic bench model and the initial clinical experience for the first FDA-cleared instrument (EXALT Model D Duodenoscope, Boston Scientific).
When compared to three makes of reusable instruments in a lab setting, the Exalt instrument compared favorably in most parameters, including overall performance, navigation/pushability, and tip control. In addition, the single-use instrument matched the image quality of two of the reusable instruments but had better image quality than the third reusable instrument. In a 6-center case series involving 13 human “roll-in” cases of intubation without cannulation plus 60 standard ERCPs, 58 of 60 full cases were successfully completed with the study instrument, while 2 crossed over to single-use instruments for confirmation of findings or success. Median physician satisfaction with the single-use instrument was rated a 9 out of 10. The full spectrum of procedural complexities graded by the American Society for Gastrointestinal Endoscopy was encountered.
Bret T. Petersen, MD, MASGE
Bio and Disclosures
Muthusamy VR, Bruno MJ, Kozarek RA, et al. Clinical evaluation of a single-use duodenoscope for endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol 2019 Nov 6. (Epub ahead of print) (https://doi.org/10.1016/j.cgh.2019.10.052)
Ross AS, Bruno MJ, Kozarek RA, et al. Novel single-use duodenoscope compared with 3 models of reusable duodenoscopes for ERCP: a randomized bench-model comparison. Gastrointest Endosc 2020;91:396-403. (https://doi.org/10.1016/j.gie.2019.08.032)